Comparative Benchmarking
In the context of the broader market, INDP competes directly with industry leaders such as SNOA and APRE. With a market capitalization of $5.35M, it holds a significant position in the sector. When comparing efficiency, INDP's gross margin of N/A stands against SNOA's 37.83% and APRE's 100.00%. Such benchmarking helps identify whether Indaptus Therapeutics Inc is trading at a premium or discount relative to its financial performance.
